(Q53118563)

11 May 2018

title

In vitro evaluation of Bifidobacterium strains of human origin for potential use in probiotic functional foods. (English)

1 reference

11 May 2018

0 references

0 references

0 references

T C Souza

1

1 reference

11 May 2018

A M Silva

2

1 reference

11 May 2018

J R P Drews

3

1 reference

11 May 2018

D A Gomes

4

1 reference

11 May 2018

C G Vinderola

5

1 reference

11 May 2018

J R Nicoli

6

1 reference

11 May 2018

publication date

1 June 2013

1 reference

11 May 2018

published in

Beneficial microbes

1 reference

11 May 2018

volume

4

1 reference

11 May 2018

issue

2

1 reference

11 May 2018

page(s)

179-186

1 reference

11 May 2018

Molecular characterization of intrinsic and acquired antibiotic resistance in lactic acid bacteria and bifidobacteria

cites work

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Inhibitory effect of conjugated alpha-linolenic acid from bifidobacteria of intestinal origin on SW480 cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Susceptibility of Lactobacillus spp. to antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antimicrobial susceptibility profiles of 32 type strains of Lactobacillus, Bifidobacterium, Lactococcus and Streptococcus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Bifidobacteria can protect from enteropathogenic infection through production of acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Specific Bifidobacterium strains isolated from elderly subjects inhibit growth of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Getting better with bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Distinct Bifidobacterium strains drive different immune responses in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Resistance of potential probiotic lactic acid bacteria and bifidobacteria of African and European origin to antimicrobials: determination and transferability of the resistance genes to other bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Probiotics: an overview of beneficial effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Aerotolerance of human clinical isolates of Prevotella spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Intrinsic tolerance of Bifidobacterium species to heat and oxygen and survival following spray drying and storage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Cell viability and immunostimulating and protective capacities of Bifidobacterium longum 51A are differentially affected by technological variables in fermented milks

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Influence of Isolation Site, Laboratory Handling and Growth Stage on Oxygen Tolerance of Fusobacterium Strains

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antagonism against Anaerobic and Facultative Bacteria through a Diffusible Inhibitory Compound Produced by aLactobacillus sp. Isolated from the Rat Fecal Microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

21 January 2018

Identifiers

DOI

10.3920/BM2012.0052

1 reference

11 May 2018

1 reference

11 May 2018